• ANKITA WAL Department of Pharmacology, Institute of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India.
  • PRANAY WAL Department of Pharmacology, Institute of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India.
  • TAMSHEEL FATIMA ROOHI Department of Pharmacology, Institute of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India.


Objective: Hypertension or raised blood pressure leads to the occurrence of morbidity and mortality rate among peoples and it was considered as the primary factor for the occurrence of various cardiac and vascular disorders include ischemic cardiac disease, myocardial necrosis, cardiac failure, renal disorder, atherosclerosis, and cerebrovascular accident. Called “silent killer” because hypertension is an asymptomatic disease in the early stages with no indications on suffered patients and leads to act as a significant factor for the occurrence of severe other cardiovascular diseases (CVDs). As berries show considerable interest in improving cardiovascular diseases because they are rich in polyphenol contents and bioactive compounds. Besides their single usage, a polyherbal combination is much better for the treatment of hypertension.

Methods: The data were collected by reviewing a combination of research and review papers from different databases such as PubMed, Medline, ScienceDirect, and Web of science using search keywords such as “hypertension,” “cardiovascular disease,” “berries,” “cranberry,” and “red raspberry” with all their synonyms and related terms.

Result: Various studies shown better associations between higher berry flavonoids and other polyphenolic components and lower the risk of cardiovascular disorders. Based on various scientific evidence, the characteristic of various biochemical processes is treated by berries with its antioxidant, antihypertensive, and anti-sclerotic and other properties.

Conclusion: This paper concludes that in the present day, there is a global increase in berry consumption, which is used in the ailment of various cardiovascular diseases. The studies which are held are needed to define their optimal dose, process, or method of preparation (formulation) and the duration of berry intervention so that these showed better treatment options for hypertension.

Keywords: Hypertension, Cardiovascular disorders, Red raspberry, Cranberry, Anthocyanins, Ellagitannins


1. Delacroix S, Chokka RG, Worthley SG. Hypertension: Pathophysiology and treatment. J Neurol Neurophysiol 2014;5:3.
2. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American society of hypertension and the international society of hypertension. J Clin Hyper 2014;16:14-26.
3. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Boehm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of hypertension (ESH) and the European society of cardiology (ESC). Blood Press 2013;22:193-278.
4. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 125 million people. Lancet 2014;383:1899-911.
5. Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005;366:1744-9.
6. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 2004;18:73-8.
7. National Institute for Health and Care Excellence. Hypertension: Clinical Management of Primary Hypertension in Adults. London: National Institute for Health and Care Excellence; 2011.
8. World Health Organization. Cardiovascular Diseases (CVDs). Geneva: World Health Organization; 2013.
9. Yang Y, Chan SW, Hu M, Walden R, Tomlinson B. Effects of some common food constituents on cardiovascular disease. ISRN Cardiol 2011;2011:397136.
10. Kizhakekuttu TJ, Widlansky ME. Natural antioxidants and hypertension: Promise and challenges. Cardiol Ther 2010;28:e20-32.
11. James PA, Oparil S, Carter BL, Cushman WC, Dennison- Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: A report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA Intern Med 2014;311:507-20.
12. Freis ED. Age, race, sex and other indices of risk in hypertension. Am J Med 1973;55:275-80.
13. Carretero OA, Oparil S. Essential hypertension: Part II: Treatment. Circulation 2000;101:446-53.
14. Beevers G, Lip GY, O’Brien E. The pathophysiology of hypertension. BMJ 2001;322:912-6.
15. Folkow BJ. Structural factor in primary and secondary hypertension. Hypertension 1990;16:89-101.
16. Mayet J, Hughes A. Cardiac and vascular pathophysiology in hypertension. Heart 2003;89:1104-9.
17. Rostrup M, Mundal HH, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hyper 1991;9:159-66.
18. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998;97:851-6.
19. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
20. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension: Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995;91:1732-8.
21. Panza JA, Quyyumi AA, Brush JE Jr., Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
22. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999;33:937-42.
23. Archer JS. Evaluation and treatment of hypertension. Prim Care Update OB/GYNS 2000;7:1-6.
24. Susalit E, Agus N, Effendi I, Tjandrawinata RR, Nofiarny D, Perrinjaquet-Moccetti T, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with captopril. Phytol Med 2011;18:251-8.
25. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000;35:544-9.
26. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med 2002;136:493-503.
27. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2001;38:1112-7.
28. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006;144:485-95.
29. Frishman WH, Beravol P, Carosella C. Alternative and complementary medicine for preventing and treating cardiovascular disease. Dis Month 2009;3:121-92.
30. Su D, Li L. Trends in the use of complementary and alternative medicine in the United States: 2002-2007. J Health Care Poor Und 2011;22:296-310.
31. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev 2011;5:30.
32. Pan SY, Zhou SF, Gao SH, Yu ZL, Zhang SF, Tang MK, et al. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med 2013;2013:25.
33. Centres for Disease Control and Prevention. The Behavioral Risk Factor Surveillance System (BRFSS). Atlanta, USA: Centres for Disease Control and Prevention; 2007.
34. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly) phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Red Sig 2013;18:1818-92.
35. Agricultural Research Services. National Nutrient Database for Standard Reference Service Release 22. Beltsville, MD: Agricultural Research Services, United States Department of Agriculture; 2009.
36. Agricultural Research Services. Database for the Flavonoid Content of Selected Foods Release 2.1, 2007. Beltsville, MD: Agricultural Research Services, United States Department of Agriculture; 2007.
37. Wu X, Kang J, Xie C, Burris R, Ferguson ME, Badger TM, et al. Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J Nutr 2010;140:1628-32.
38. Swanson J, Weber CA, Finn CE, Fernandez-Fernandez F, Sargent D, Carlson JE, et al. Breeding, genetics and genomics of Rubus. In: Folta K, Kole C, editors. Genetics, Genomics and Breeding of Berries. New Hampshire: Science Publications; 2011. p. 64-113.
39. USDA Agricultural Research Services. National Nutrient Database for Standard Reference Service Release 27 and the Flavonoid Content of Selected Foods Release 3.1. Washington, DC: USDA Agricultural Research Services; 2014.
40. Rao AV, Snyder DM. Raspberries and human health: A review. J Agric Food Chem 2010;58:3871-83.
41. Jennings DL. Raspberries and Blackberries: Their Breeding, Diseases and Growth. United States: Academic Press; 1988.
42. US Department of Agriculture Research Service. USDA National Nutrient Database for Standard Reference, Release 21: Fruits and Fruit Juice. United States: US Department of Agriculture Research Service; 2008. p. 719-20.
43. Hummer KE. Rubus pharmacology: Antiquity to the present. Hort Sci 2010;45:1587-91.
44. Tasaki M, Umemura T, Maeda M, Ishii Y, Okamura T, Inoue T, et al. Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem Toxicol 2008;46:1119-24.
45. Graham J, Woodhead M. Rubus. In: Wild Crop Relatives: Genomic and Breeding Resources. Berlin, Heidelberg: Springer; 2011. p. 179-96.
46. Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317-33.
47. Waterman PG, Mole S. Analysis of Phenolic Plant Metabolites. 1st ed. Hoboken, NJ: Wiley-Blackwell; 1994.
48. Vainio H, Bianchini F. Fruit and Vegetables. Lyon, France: IARC; 2003. p. 1-19.
49. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005;81:317-25.
50. Kaur C, Kapoor HC. Antioxidants in fruits and vegetables-the millennium health. Int J Food Sci Technol 2001;36:703-25.
51. Prior RL, Wu X, Gu L, Hager TJ, Hager A, Howard LR. Whole berries versus berry anthocyanins: Interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 2008;56:647-53.
52. Määttä-Riihinen KR, Kamal-Eldin A, Törrönen AR. Identification and quantification of phenolic compounds in berries of Fragaria and Rubus species (family Rosaceae). J Agric Food Chem 2004;52:6178-87.
53. de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages J Agric Food Chem 2000;48:5331-7.
54. Arts IC, van de Putte B, Hollman PC. Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 2000;48:1746-51.
55. Heinonen IM, Meyer AS, Frankel EN. Antioxidant activity of berry phenolics on human low-density lipoprotein and liposome oxidation. J Agric Food Chem 1998;46:4107-12.
56. Harborne JB, Baxter H. The Handbook of Natural Flavonoids. Vol. 1., Vol. 2. United States: John Wiley and Sons; 1999.
57. Middleton E, Kandaswami C, Harborne J. The Flavonoids: Advances in Research Since 1986. New York: Chapman & Hall/CRC; 1993.
58. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-49.
59. Kassim A, Poette J, Paterson A, Zait D, McCallum S, Woodhead M, et al. Environmental and seasonal influences on red raspberry anthocyanin antioxidant contents and identification of quantitative traits loci (QTL). Mol Nutr Food Res 2009;53:625-34.
60. Mattila P, Hellström J, Törrönen R. Phenolic acids in berries, fruits, and beverages. J Agric Food Chem 2006;54:7193-9.
61. Koponen JM, Happonen AM, Mattila PH, Törrönen AR. Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. J Agric Food Chem 2007;55:1612-9.
62. Hellström JK, Torronen AR, Mattila PH. Proanthocyanidins in common food products of plant origin. J Agric Food Chem 2009;57:7899-906.
63. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 2004;134:613-7.
64. Mazur WM, Uehara M, Wähälä K, Adlercreutz H. Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. B J Nutr 2000;83:381-7.
65. Bobinait? R, Viškelis J. Anthocyanins: Occurrence, bioactivity and bioavailability, with special reference to the anthocyanins of raspberries (a review). Sodininkyst? Daržininkyst? 2013;32:39-47.
66. Beekwilder J, Jonker H, Meesters P, Hall RD, van der Meer IM, de Vos CH. Antioxidants in raspberry: On-line analysis links antioxidant activity to a diversity of individual metabolites. J Agric Food Chem 2005;53:3313-20.
67. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 2006;54:4069-75.
68. Mazur SP, Nes A, Wold AB, Remberg SF, Aaby K. Quality and chemical composition of ten red raspberries (Rubus idaeus L.) genotypes during three harvest seasons. Food Chem 2014;160:233-40.
69. Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting the oxidation of human low-density lipoproteins. J Agric Food Chem 1995;43:890-4.
70. Kuhnau J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
71. Wood RJ. Bioavailability: Definition, general aspects and fortificants. In: Encyclopaedia of Human Nutrition. 2nd ed. Oxford: Elsevier Ltd.; 2005. p. 195-201.
72. Daniel EM, Ratnayake S, Kinstle T, Stoner GD. The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins. J Nat Prod 1991;54:946-52.
73. Laitinen LA, Tammela PS, Galkin A, Vuorela HJ, Marvola ML, Vuorela PM. Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers. Pharm Res 2004;21:1904-16.
74. Cao G, Muccitelli HU, Sanchez-Moreno C, Prior RL. Anthocyanins are absorbed in glycated forms in elderly women: A pharmacokinetic study. Am J Clin Nutr 2001;73:920-6.
75. Kay CD. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006;19:137-46.
76. McGhie TK, Walton MC. The bioavailability and absorption of anthocyanins: Towards a better understanding. Mol Nutr Food Res 2007;51:702-13.
77. Mullen W, Edwards CA, Serafini M, Crozier A. Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J Agric Food Chem 2008;56:713-9.
78. Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002;50:7731-7.
79. Mülleder U, Murkovic M, Pfannhauser W. Urinary excretion of cyanidin glycosides. J Biochem Biol Meth 2002;53:61-6.
80. Talavera S, Felgines C, Texier O, Besson C, Lamaison JL, Rémésy C. Anthocyanins are efficiently absorbed from the stomach in anaesthetized rats. J Nutr 2003;133:4178-82.
81. Talavera S, Felgines C, Texier O, Besson C, Manach C, Lamaison JL, et al. Anthocyanins are efficiently absorbed from the small intestine in rats. J Nutr 2004;134:2275-9.
82. Matuschek MC, Hendriks WH, McGhie TK, Reynolds GW. The jejunum is the main site of absorption for anthocyanins in mice. J Nutr Biochem 2006;17:31-6.
83. McDougall GJ, Dobson P, Smith P, Blake A, Stewart D. Assessing potential bioavailability of raspberry anthocyanins using an in the vitro digestion system. J Agric Food Chem 2005;53:5896-904.
84. Passamonti S, Vrhovsek U, Mattivi F. The interaction of anthocyanins with bilitranslocase. Biochem Biophys Res Commun 2002;296:631-6.
85. Passamonti S, Vrhovsek U, Vanzo A, Mattivi F. The stomach as a site for anthocyanins absorption from food. FEBS Lett 2003;544:210-3.
86. Hollman PC. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol 2004;42:74-83.
87. Felgines C, Talavera S, Texier O, Gil-Izquierdo A, Lamaison JL, Remesy C. Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans. J Agric Food Chem 2005;53:7721-7.
88. Francis FJ. Analysis of anthocyanins. In: Markakis P, editor. Anthocyanins as Food Colours. United States: Academic Press; 1982. p. 182-208.
89. Fuleki T, Francis FJ. Quantitative methods for anthocyanins. 1. Extraction and determination of total anthocyanin in cranberries. J Food Sci 1968;33:72-7.
90. Harborne JB. The chromatographic identification of anthocyanin pigments. J Chroma A 1958;1:473-88.
91. Francis FJ, Harborne JB. Anthocyanins of the garden huckleberry, Solanum guineense. J Food Sci 1966;31:524-8.
92. Andersen OM. Chromatographic separation of anthocyanins in cowberry (lingonberry) Vaccinium vitis?idaea L. J Food Sci 1985;50:1230-2.
93. Bakker J, Timberlake CF. The distribution of anthocyanins in grape skin extracts of port wine cultivars as determined by high-performance liquid chromatography. J Sci Food Agric 1985;36:1315-24.
94. Harborne JB. Comparative Biochemistry of the Flavonoids. London, England: Academic Press; 1987. p. 1-36.
95. Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ, Spencer JP. Polyphenols and human health: Prevention of disease and mechanisms of action. Nutrients 2010;2:1106-31.
96. Juránek I, Bezek S. Controversy of free radical hypothesis: Reactive oxygen species-cause or consequence of tissue injury? Gen Physiol Biophys 2005;24:263-78.
97. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009;81:457-64.
98. Garcia-Alonso M, Rimbach G, Sasai M, Nakahara M, Matsugo S, Uchida Y, et al. Electron spin resonance spectroscopy studies on the free radical scavenging activity of wine anthocyanins and proanthocyanins. Mol Nutr Food Res 2005;49:1112-9.
99. García-Alonso M, Rimbach G, Rivas-Gonzalo JC, de Pascual- Teresa S. Antioxidant and cellular activities of anthocyanins and their corresponding vitisins a study in platelets, monocytes, and human endothelial cells. J Agric Food Chem 2004;52:3378-84.
100. Oak MH, Bedoui JE, Madeira SF, Chalupsky K, Schini-Kerth VB. Delphinidin and cyanidin inhibit PDGFAB-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br J Pharmacol 2006;149:283-90.
101. Sies H, Stahl W, Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr 2005;135:969-72.
102. Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin-converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 2003;555:597-600.
103. Barbehenn RV, Jones CP, Hagerman AE, Karonen M, Salminen JP. Ellagitannins have greater oxidative activities than condensed tannins and galloyl glucose at high pH: Potential impact on caterpillars. J Chem Econ 2006;32:2253-67.
104. Quideau S. Chemistry and Biology of Ellagitannins: An Underestimated Class of Bioactive Plant Polyphenols. Singapore: World Scientific; 2009.
105. Clifford MN, Scalbert A. Ellagitannins-nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1118-25.
106. Haddock EA, Gupta RK, Al-Shafi SM, Layden K, Haslam E, Magnolato D. The metabolism of gallic acid and hexahydroxy diphenic acid in plants: Biogenetic and molecular taxonomic considerations. Phytochemistry 1982;21:1049-62.
107. Bobinait? R, Viškelis P, Šarkinas A, Venskutonis PR. Phytochemical composition, antioxidant and antimicrobial properties of raspberry fruit, pulp, and marc extracts. CyTA J Food 2013;11:334-42.
108. Cerdá B, Tomás-Barberán FA, Espín JC. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability. J Agric Food Chem 2005;53:227-35.
109. González-Barrio R, Edwards CA, Crozier A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: In vivo and in vitro studies. Drug Metab Dispos 2011;39:1680-8.
110. González-Barrio R, Borges G, Mullen W, Crozier A. Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J Agric Food Chem 2010;58:3933-9.
111. Zafra-Stone S, Yasmin T, Bagchi M, Chatterjee A, Vinson JA, Bagchi D. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res 2007;51:675-83.
112. European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies. Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J 2011;9:24-74.
113. Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 2010;4:351-60.
114. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the working group on endothelin and endothelial factors of the European society of hypertension. J Hypertens 2005;23:7-17.
115. Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J, et al. Methods for evaluating endothelial function: A position statement from the European society of cardiology working group on peripheral circulation. Eur J Cardiovasc Prev Rehabil 2011;18:775-89.
116. Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10:4-18.
117. Viljanen K, Kylli P, Kivikari R, Heinonen M. Inhibition of protein and lipid oxidation in liposomes by berry phenolics. J Agric Food Chem 2004;52:7419-24.
118. Seeram NP, Nair MG. Inhibition of lipid peroxidation and structure-activity-related studies of the dietary constituent anthocyanins,
anthocyanidins, and catechins. J Agric Food Chem 2002;50:5308-12.
119. Meyer AS, Heinonen M, Frankel EN. Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL oxidation. Food Chem 1998;61:71-5.
120. Serraino I, Dugo L, Dugo P, Mondello L, Mazzon E, Dugo G, et al. Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci 2003;73:1097-114.
121. Mullen W, McGinn J, Lean ME, MacLean MR, Gardner P, Duthie GG, et al. Ellagitannins, flavonoids, and other phenolics in red raspberries and their contribution to antioxidant capacity and vasorelaxation properties. J Agric Food Chem 2002;50:5191-6.
122. Wang J, Mazza G. Effects of anthocyanins and other phenolic compounds on the production of tumour necrosis factor ? in LPS/ IFN-?-activated RAW 264.7 macrophages. J Agric Food Chem 2002;50:4183-9.
123. Wang J, Mazza G. Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-?-activated RAW 264.7 macrophages. J Agric Food Chem 2002;50:850-7.
124. Vattem DA, Ghaedian R, Shetty K. Enhancing health benefits of berries through phenolic antioxidant enrichment: Focus on cranberry. Asia Pac J Clin Nutr 2005;14:120.
125. Côté J, Caillet S, Doyon G, Sylvain JF, Lacroix M. Bioactive compounds in cranberries and their biological properties. Crit Rev Food Sci Nutr 2010;50:666-79.
126. Neto CC. Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 2007;51:652-64.
127. Grace MH, Esposito D, Dunlap KL, Lila MA. Comparative analysis of phenolic content and profile, antioxidant capacity, and anti-inflammatory bioactivity in wild Alaskan and commercial Vaccinium berries. J Agric Food Chem 2013;62:4007-17.
128. Blumberg JB, Camesano TA, Cassidy A, Kris-Etherton P, Howell A, Manach C, et al. Cranberries and their bioactive constituents in human health. Adv Nutr 2013;4:618-32.
129. Pappas E, Schaich KM. Phytochemicals of cranberries and cranberry products: Characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 2009;49:741-81.
130. Zuo Y, Wang C, Zhan J. Separation, characterization, and quantitation of benzoic and phenolic antioxidants in American cranberry fruit by GC-MS. J Agric Food Chem 2002;50:3789-94.
131. Mazur B, Borowska EJ, Polak M. Content of Vitamin C in and antioxidant capacity of wild and cultivated cranberry fruit and their pulps. Zyw Nauka Technol Jak 2009;2:130-7.
132. McKay DL, Chen CY, Zampariello CA, Blumberg JB. Flavonoids and phenolic acids from cranberry juice are bioavailable and bioactive in healthy older adults. Food Chem 2015;168:233-40.
133. Zhang K, Zuo Y. GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juice. J Agric Food Chem 2004;52:222-7.
134. Ohnishi R, Ito H, Kasajima N, Kaneda M, Kariyama R, Kumon H, et al. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 2006;70:1681-7.
135. Wang C, Zuo Y, Vinson JA, Deng Y. Absorption and excretion of cranberry-derived phenolics in humans. Food Chem 2012;132:1420-8.
136. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 2008;99:352-9.
137. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption Metabolism. Br J Nutr 2005;54:856-61.
138. DiCorleto PE, Gimbrone MA. Atherosclerosis and coronary artery disease. Vasc Endothelium 1996;1:387-99.
139. Shukla R, Omray LK. Formulation and characterization of diltiazem transdermal system for the treatment of hypertension. Int J Curr Pharm Res 2016;8:12-5.
140. Nakagami H, Morishita R. Hypertension and osteoporosis. Clin Calcium 2013;23:497-503.
141. Thungmungmee S, Wisidsri N, Khobjai W, Dumrongphuttidecha T, Jamkom K, Techaeoi S. The characteristics and antioxidant activities of chaba maple (Hibiscus acetosella) homemade jam. Int J Appl Pharm 2019;11:52-5.
142. Yu YM, Wang ZH, Liu CH, Chen CS. Ellagic acid inhibits IL- 1betainduced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr 2007;97:692-8.
143. Chang WC, Yu YM, Chiang SY, Tseng CY. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: Studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br J Nutr 2008;99:709-14.
144. Ding Y, Zhang B, Zhou K, Chen M, Wang M, Jia Y, et al. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: Role of Nrf2 activation. Int J Cardiol 2014;175:508-14.
145. Chao PC, Hsu CC, Yin MC. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond) 2009;6:33.
146. Yu YM, Chang WC, Wu CH, Chiang SY. Reduction of oxidative stress and apoptosis in hyperlipidaemic rabbits by ellagic acid. J Nutr Biochem 2005;16:675-81.
147. Lin MC, Yin MC. Preventive effects of ellagic acid against doxorubicin-induced cardiotoxicity in mice. Cardiovasc Toxicol 2013;13:185-93.
148. Panchal SK, Ward L, Brown L. Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr 2013;52:559-68.
149. Pieszka M, Tombarkiewicz B, Roman A, Migda1 W, Niedzió1ka J. Effect of bioactive substances found in rapeseed, raspberry and strawberry seed oils on blood lipid profile and selected parameters of oxidative status in rats. Environ Toxicol Pharmacol 2013;36:1055-62.
150. Freese R, Vaarala O, Turpeinen AM, Mutanen M. No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apple in healthy subjects. Eur J Nutr 2004;43:175-82.
151. Lee IT, Chan YC, Lin CW, Lee WJ, Sheu WH. Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Diab Med 2008;25:1473-7.
152. Wilson T, Luebke JL, Morcomb EF, Carrell EJ, Leveranz MC, Kobs L, et al. Glycemic responses to sweetened dried and raw cranberries in humans with Type 2 diabetes. J Food Sci 2010;75:H218-23.
153. caBasu A, Betts NM, Ortiz J, Simmons B, Wu M, Lyons TJ. Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 2011;31:190-6.
154. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 2006;96:357-6.
155. Verma H, Prasad SB, Yashwant SH. Herbal drug delivery system: A modern era prospective. Int J Curr Pharm Res 2013;4:88-101.
71 Views | 102 Downloads
How to Cite
WAL, A., P. WAL, and T. F. ROOHI. “A REVIEW ON ROLE OF BERRIES AND ITS BIOACTIVE COMPOUNDS IN TREATING HYPERTENSION”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 8, May 2020, pp. 3-12, doi:10.22159/ajpcr.2020.v13i8.37932.
Review Article(s)